Tardive dyskinesia and serum iron indices

Biological Psychiatry

Volumn 44, Issue 6, 1998, Pages 493-498

  Wirshing, Donna A ^a,b   Bartzokis, George ^a,b   Pierre, Joseph M ^b   Wirshing, William C ^a,b   Sun, Albert ^c   Tishler, Todd A ^a   Marder, Stephen R ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akathisia; Iron; Neuroleptics; Schizophrenia; Serum ferritin; Tardive dyskinesia

Indexed keywords

DOPAMINE 2 RECEPTOR; FERRITIN; FLUPHENAZINE; SEROTONIN;

ADULT; AKATHISIA; ARTICLE; CHOREOATHETOSIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON BINDING CAPACITY; IRON METABOLISM; MALE; PRIORITY JOURNAL; RISK FACTOR; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FERRITINS; FLUPHENAZINE; HUMANS; IRON; MALE; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 0032530882     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00453-8     Document Type: Article

References (48)

1. Adler L.A., Peselow E., Rotrosen J., Duncan E., Lee M., Rosenthal M., et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatry. 150:1993;1405-1407.
2. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. 1980;American Psychiatric Press, Washington, DC.
3. Ashkenazi R., Ben-Shachar D., Youdim M.B.H. Nutritional iron and dopamine binding sites in the rat brain. Pharmacol Biochem Behav. 17:(suppl 1):1982;43-47.
4. Barnes T.R.E. A rating scale for drug-induced akathisia. Br J Psychiatry. 154:1989;672-676.
5. Bartzokis G., Marder S.R. Magnetic resonance imaging evaluation of brain iron levels. Biol Psychiatry. 38:1995;133-134.
6. Bartzokis G., Garber J., Marder S.R.T., Oldendorf W.H. MRI in tardive dyskinesia Shortened left caudate T2 . Biol Psychiatry. 28:1990;1027-1036.
7. Bartzokis G., Aravagiri M., Oldendorf W.H., Mintz J., Marder S.R. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med. 29:1993;459-464.
8. Bartzokis G., Mintz J., Sultzer D., Marx P., Herzberg J.S., Phelan C.K., et al. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol. 15:1994;1129-1138.
9. Bartzokis G., Beckson M., Hance D.B., Marx P., Foster J.A., Marder S.R. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging. 15:1997;29-35.
10. Ben-Shachar D., Youdim M.B.H. Neuroleptic induced dopamine receptor supersensitivity and tardive dyskinesia may involve altered brain metabolism. Br J Pharmacol. 90:1987;95.
11. Ben-Shachar D., Youdim M.B.H. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity. J Neurochem. 54:1989;1136-1141.
12. 3 uptake. J Neurochem. 62:1994;1112-1118.
13. Brown K.W., Glen S.E., White T. Low serum iron status and akathisia. Lancet. 30:1987;1234-1236.
14. 2 relaxation times in schizophrenia A quantitative magnetic resonance imaging study in relation to tardive dyskinesia . Psychiatry Res. 61:1995;95-102.
15. Cadet J.L., Lohr J.B. Possible involvement of free radicals in neuroleptic-induced movement disorders. Ann NY Acad Sci. 570:1989;176-185.
16. Campbell W.G., Raskind M.A., Gordon T., Shaw C.M. Iron pigment in the brain of a man with tardive dyskinesia. Am J Psychiatry. 3:1985;364-365.
17. Casanova M.F., Comparini S.O., Kim R.W., Kleinman J.E. Staining intensity of brain iron in patients with schizophrenia A postmortem study . J Neuropsychiatr Clin Neurosci. 4:1992;36-41.
18. Custer E.M., Finch C.A., Sobel R.E., Zettner A. Population norms for serum ferritin. J Lab Clin Med. 126:1995;88-94.
19. Dallman P.R., Spirito R.A. Brain iron in the rat Extremely slow turnover in normal rats may explain long-lasting effects of early iron deficiency . J Nutr. 107:1977;1075-1081.
20. Demasi M., Bechara E.J.H. Chlorpromazine stimulatory effect on iron uptake by rat brain synaptosomes. Biochem Pharmacol. 51:1996;331-337.
21. Abnormal Involuntary Movement Scale. 1974;Alcohol, Drug Abuse, and Mental Health Administration, NIMH, Washington, DC.
22. Drayer B.P., Burger P., Darwin R., Riederer S., Herfkens R., Johnson G.A. Magnetic resonance imaging of brain iron. AJNR Am J Neuroradiol. 7:1986;373-380.
23. Dwork A.J., Lawler G., Zybert P.A., Durkin M., Osman M., Willson N., et al. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res. 518:1990;31-39.
24. Egan M.F., Hyde T.M., Albers G.W., Elkashef A., Alexander R.C., Reeve A., et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry. 149:1992;773-777.
25. Elkashef A.M., Ruskin P.E., Bacher N., Barrett D. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry. 147:1990;505-506.
26. Elkashef A.M., Egan M.F., Frank J.A., Hyde T.M., Lewis B.K., Wyatt R.J. Basal ganglia iron in tardive dyskinesia An MRI study . Biol Psychiatry. 35:1994;16-21.
27. Gold R., Lenox R.H. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. J Clin Psychiatry. 56:1995;476-483.
28. Hallgren B., Sourander P. The effect of age on non-haemin iron in the human brain. J Neurochem. 3:1958;41-51.
29. Halliwell B., Gutteridge J.M.C. Iron as biological pro-oxidant. ISI Atlas Sci Biochem. 1:1988;48-52.
30. Hill J.M. The distribution of iron in the brain. Youdim M.B.H. Brain Iron Neurochemistry and Behavioural Aspects . 1988;1-24 Taylor and Francis, London.
31. Hunter R., Blackwood W., Smith M.C., Cummings J.N. Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. J Neurol Sci. 7:1968;263-273.
32. Jeste D.V., Caligiuri M.P. Tardive dyskinesia. Schizophr Bull. 19:1993;303-315.
33. Lammi-Keefe C.J., Lickteig E.S., Ahluwalia N., Haley N.R. Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis. J Am Diet Assoc. 96:1996;247-251.
34. Leenders K.L., Antonini A., Schwarzbach R., Smith-Jones P., Reist H., Ben-Shachar D., et al. Blood to brain iron uptake in one Rhesus monkey using [Fe-52]-citrate and positron emission tomography (PET) Influence of haloperidol . J Neural Transm Suppl. 43:1994;123-132.
35. Lohr J.B., Cadet J.L., Lohr M.A., Larson L., Wasli E., Wade L., et al. Vitamin E in the treatment of tardive dyskinesia The possible involvement of free radical mechanisms . Schizophr Bull. 14:1988;291-296.
36. Marder S.R., Wirshing W.C., Mintz J., Mintz J., Johnson K., Eckman T.A., et al. Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. Am J Psychiatry. 153:1996;1585-1592.
37. Milman N., Clausen J.O., Jordal R. Iron status in young Danish men and women A population survey comprising 548 individuals . Ann Hematol. 70:1995;215-221.
38. Peet M., Laugharne J., Rangarajan N., Reynolds G.P. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol. 8:1993;151-153.
39. Sachdev P. Neuroleptic-induced movement disorders and body iron status. Prog Neuropsychopharmacol Biol Psychiatry. 16:1992;647-653.
40. Sachdev P. The neuropsychiatry of brain iron. J Neuropsychiatry Clin Neurosci. 5:1993;18-29.
41. Salonen J.T., Nyyssonen K., Korpela H., Tuomilehto J., Seppanen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
42. Spatz H. Uber des Eisennachweis im Gehirn besonders in Zentren des extrapyramidal motioschen System. Z Gesamte Neurol Psychiatrie. 77:1922;261-370.
43. Tuomainen T.P., Salonen R., Nyyssonen K., Salonen J.T. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. Br Med J Clin Res. 314:1997;793-794.
44. 2 of ferritin solutions Effect of loading factor . Magn Reson Med. 36:1996;61-65.
45. Weiner W.J., Nausieda P.A., Klawans H.L. Effect of chlorpromazine on central nervous system concentrations of manganese, iron, and copper. Life Sci. 20:1977;1181-1186.
46. Yassa R., Nair N.P. A 10-year follow-up study of tardive dyskinesia. Acta Psychiatr Scand. 86:1992;262-266.
47. Youdim M.B.H., Ben-Shachar D., Yehuda S. Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am J Clin Nutr. 50:(suppl 3):1989;607-617.
48. Youdim M.B.H., Ben-Shachar D., Yehuda S., Riederer P. The role of iron in the basal ganglion. Adv Neurol. 53:1990;155-162.